COVID-19 pandemic accelerated adoption of shorter, lower-burden (lower cost) breast radiation therapy
The COVID-19 pandemic accelerated the adoption of shorter-course radiation therapy for women with early-stage breast cancer, leading to reduced treatment burden and lower health care spending, according to a new study published in the American Journal of Clinical Oncology.
<p>The COVID-19 pandemic accelerated the adoption of shorter-course radiation therapy for women with early-stage breast cancer, leading to reduced treatment burden and lower health care spending, according to a new study published in the American Journal of Clinical Oncology.</p>